On Thursday, France’s BPCE, which is in the process of delisting its Natixis investment banking arm, announced plans to boost its revenues by 2024 by partly increasing its focus on sustainable investing. It expects the move to generate additional revenues… Read More ›
boost revenues
Pfizer Inc sells Chinese biosimilar assets to XuXi Biologics Inc
On Wednesday, in a statement Pfizer Inc said, it has decided to stop producing biosimilar products in China; it has also decided to sell one of its business unit in the eastern city of Hangzhou to WuXi Biologics Inc. “The… Read More ›